Comparative survival analysis of bladder preservation therapy versus radical cystectomy in muscle‐invasive bladder cancer
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Nai‐Wen Kang, Yin‐Hsun Feng, Kuei‐Li Lin, Yi‐Chen Chen, Chung‐Han Ho, Ching‐Chieh Yang |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer
by: Alberto Mendoza‐Valderrey, et al.
Published: (2024)
by: Alberto Mendoza‐Valderrey, et al.
Published: (2024)
POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1
by: Ge Liu, et al.
Published: (2024)
by: Ge Liu, et al.
Published: (2024)
Efficiency of transurethral en‐bloc resection vs. conventional transurethral resection for non‐muscle‐invasive bladder cancer: An umbrella review
by: Deng‐xiong Li, et al.
Published: (2024)
by: Deng‐xiong Li, et al.
Published: (2024)
Impact of rural location on receipt of standard of care treatment and survival for locally advanced bladder cancer in Louisiana
by: Megan Escott, et al.
Published: (2024)
by: Megan Escott, et al.
Published: (2024)
PGK1 can affect the prognosis and development of bladder cancer
by: Mingde Gao, et al.
Published: (2024)
by: Mingde Gao, et al.
Published: (2024)
The current and future role of systemic therapy in non–muscle‐invasive bladder cancer
by: Alon Lazarovich, et al.
Published: (2025)
by: Alon Lazarovich, et al.
Published: (2025)
New clinical insights into the treatment of benign uretero‐ileal anastomotic stricture following radical cystectomy and urinary diversion
by: Yixuan Mou, et al.
Published: (2024)
by: Yixuan Mou, et al.
Published: (2024)
Association of household net worth with healthcare costs after radical cystectomy using real‐world data
by: Samuel L. Washington, et al.
Published: (2024)
by: Samuel L. Washington, et al.
Published: (2024)
FDA approves durvalumab for perioperative immunotherapy for patients with muscle‐invasive bladder cancer
by: Mary Beth Nierengarten
Published: (2025)
by: Mary Beth Nierengarten
Published: (2025)
Optimizing Systemic Therapy for Advanced Sarcomas: Outcomes With Gemcitabine, Docetaxel, Cisplatin, and Everolimus in a Retrospective Single‐Center Study
by: Wen‐Chi Wu, et al.
Published: (2026)
by: Wen‐Chi Wu, et al.
Published: (2026)
Disability‐Adjusted Life Years ( DALYs ) due to Breast, Cervical, Colorectal and Oral Cancers in Taiwan Regions
by: Cheng‐Chieh Hsieh, et al.
Published: (2025)
by: Cheng‐Chieh Hsieh, et al.
Published: (2025)
Psoas muscle area is an independent survival prognosticator in patients undergoing surgery for long‐bone metastases
by: Chia‐Che Lee, et al.
Published: (2024)
by: Chia‐Che Lee, et al.
Published: (2024)
Quality‐of‐life comparison between intensity‐modulated proton therapy and volumetric‐modulated arc therapy in patients with nasopharyngeal carcinoma: Preliminary findings from real‐world data
by: Ching‐Nung Wu, et al.
Published: (2024)
by: Ching‐Nung Wu, et al.
Published: (2024)
phi and phiD predict adverse pathological features after radical prostatectomy for prostate cancer in Chinese population
by: Ruofan Shi, et al.
Published: (2024)
by: Ruofan Shi, et al.
Published: (2024)
Predicting survival in patients with buccal cancer: A study based on SEER database and external validation in China
by: Yongmei Tan, et al.
Published: (2024)
by: Yongmei Tan, et al.
Published: (2024)
The miRNAs 203a/210‐3p/5001‐5p regulate the androgen/androgen receptor/YAP‐induced migration in prostate cancer cells
by: Chieh Huo, et al.
Published: (2024)
by: Chieh Huo, et al.
Published: (2024)
Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer
by: Jacob I. Taylor, et al.
Published: (2024)
by: Jacob I. Taylor, et al.
Published: (2024)
Prediction of 5‐year overall survival of diffuse large B‐cell lymphoma on the pola‐R‐CHP regimen based on 2‐year event‐free survival and progression‐free survival
by: Wan‐Ru Zhang, et al.
Published: (2024)
by: Wan‐Ru Zhang, et al.
Published: (2024)
Physical activity and risks of recurrence and progression among patients with non‐muscle invasive bladder cancer
by: Ivy Beeren, et al.
Published: (2025)
by: Ivy Beeren, et al.
Published: (2025)
Smoking behavior and the risks of tumor recurrence and progression in patients with non‐muscle‐invasive bladder cancer
by: Joann Kiebach, et al.
Published: (2024)
by: Joann Kiebach, et al.
Published: (2024)
Is elective neck dissection justified in cT2N0M0 oral cavity cancer defined according to the AJCC eighth edition staging system?
by: Tsung‐Ming Chen, et al.
Published: (2024)
by: Tsung‐Ming Chen, et al.
Published: (2024)
Relationship between educational level and survival of patients with cancer: A multicentre cohort study
by: Xiao‐Yue Liu, et al.
Published: (2024)
by: Xiao‐Yue Liu, et al.
Published: (2024)
PriorClinico‐RadiologicalFeatures InformedMulti‐Modal MRImages Convolution Neural Network: A novel deep learning framework for prediction of lymphovascular invasion in breast cancer
by: Hong Zheng, et al.
Published: (2024)
by: Hong Zheng, et al.
Published: (2024)
Exploring the symptoms and psychological experiences among lung cancer convalescence patients after radical lobectomy: A qualitative study
by: Julan Xiao, et al.
Published: (2024)
by: Julan Xiao, et al.
Published: (2024)
Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study
by: Cheng‐Lung Hsu, et al.
Published: (2024)
by: Cheng‐Lung Hsu, et al.
Published: (2024)
Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis
by: Kari Hemminki, et al.
Published: (2024)
by: Kari Hemminki, et al.
Published: (2024)
Magnetic resonance imaging‐based radiomics nomogram for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high‐risk non‐metastatic prostate cancer
by: Xiao‐Hui Wu, et al.
Published: (2024)
by: Xiao‐Hui Wu, et al.
Published: (2024)
Hearing preservation after stereotactic radiosurgery for sporadic intracanalicular vestibular schwannomas classified as Koos grade 1
by: Ho Kang, et al.
Published: (2024)
by: Ho Kang, et al.
Published: (2024)
CT ‐determined low skeletal muscle index predicts poor prognosis in patients with colorectal cancer
by: Yue Feng, et al.
Published: (2024)
by: Yue Feng, et al.
Published: (2024)
The survival outcomes of localized low‐risk prostate cancer, a population‐based study using NCDB
by: Shifeng Mao, et al.
Published: (2024)
by: Shifeng Mao, et al.
Published: (2024)
Outcomes after fertility‐sparing surgery of early‐stage ovarian cancer: A nationwide population‐based study
by: Chia‐Yi Lee, et al.
Published: (2024)
by: Chia‐Yi Lee, et al.
Published: (2024)
Polygenic Risk Score as a Predictor of Bone Fracture or Osteoporosis in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
by: Ying‐Qiang Liu, et al.
Published: (2025)
by: Ying‐Qiang Liu, et al.
Published: (2025)
East Asian patients who received immunotherapy‐based therapy associated with improved survival benefit in advanced non‐small cell lung cancer: An updated meta‐analysis
by: Yueyuan Yao, et al.
Published: (2024)
by: Yueyuan Yao, et al.
Published: (2024)
Escalated‐dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States
by: Christopher Shi, et al.
Published: (2024)
by: Christopher Shi, et al.
Published: (2024)
Urban relatives ameliorate survival disparities for genitourinary cancer in rural patients
by: Mouneeb Choudry, et al.
Published: (2024)
by: Mouneeb Choudry, et al.
Published: (2024)
Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer
by: Yuxuan Hao, et al.
Published: (2024)
by: Yuxuan Hao, et al.
Published: (2024)
Effect of Medicaid expansion on cancer treatment and survival among Medicaid beneficiaries and the uninsured
by: Kristin M. Primm, et al.
Published: (2024)
by: Kristin M. Primm, et al.
Published: (2024)
Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease
by: XiaoYan Yue, et al.
Published: (2024)
by: XiaoYan Yue, et al.
Published: (2024)
Fertility preservation in male adolescents with cancer (2011–2020): A retrospective study in China
by: Shasha Liu, et al.
Published: (2024)
by: Shasha Liu, et al.
Published: (2024)
Evaluating artificial intelligence–enhanced digital urine cytology for bladder cancer diagnosis
by: Tien‐Jen Liu, et al.
Published: (2024)
by: Tien‐Jen Liu, et al.
Published: (2024)
Similar Items
-
Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer
by: Alberto Mendoza‐Valderrey, et al.
Published: (2024) -
POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1
by: Ge Liu, et al.
Published: (2024) -
Efficiency of transurethral en‐bloc resection vs. conventional transurethral resection for non‐muscle‐invasive bladder cancer: An umbrella review
by: Deng‐xiong Li, et al.
Published: (2024) -
Impact of rural location on receipt of standard of care treatment and survival for locally advanced bladder cancer in Louisiana
by: Megan Escott, et al.
Published: (2024) -
PGK1 can affect the prognosis and development of bladder cancer
by: Mingde Gao, et al.
Published: (2024)